FDA Issues First EUA for SARS-CoV-2 Diagnostic Testing Intended to Test Asymptomatic Individuals
New EUA opens the door for increased availability of COVID-19 testing for asymptomatic individuals.
Routine COVID-19 Screening of Asymptomatic People Creates Increased Demand for SARS-CoV-2 Diagnostic Testing
Screening asymptomatic people regardless of known or unknown COVID-19 exposure is useful, but it will be important to ensure that this testing is used appropriately and that contingency plans are in place to modify operations based on test results.